Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes

Cancer. 1992 May 1;69(9):2271-5. doi: 10.1002/1097-0142(19920501)69:9<2271::aid-cncr2820690911>3.0.co;2-7.

Abstract

Metastases from cystosarcoma phyllodes are rare, and treatment generally is ineffective. Four patients were treated with ifosfamide (alone in three and combined with doxorubicin in one). Two patients had complete remissions that lasted 26 and 61+ months. One other patient had a partial response that lasted 13 months. The complete responders were both treated as soon as metastases appeared, when they had only a small volume of disease. This appears to represent a significant improvement on other described regimens for this condition, and further trials of ifosfamide are warranted. Close follow-up of patients at high risk for metastases is suggested.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Ifosfamide / therapeutic use*
  • Mesna / therapeutic use
  • Middle Aged
  • Neoplasm Metastasis
  • Phyllodes Tumor / drug therapy*
  • Phyllodes Tumor / pathology

Substances

  • Mesna
  • Ifosfamide